Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia
Authors
Keywords
-
Journal
JAMA Psychiatry
Volume -, Issue -, Pages -
Publisher
American Medical Association (AMA)
Online
2022-01-13
DOI
10.1001/jamapsychiatry.2021.3799
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis
- (2021) Dan Siskind et al. BRITISH JOURNAL OF PSYCHIATRY
- Evaluation of polygenic prediction methodology within a reference-standardized framework
- (2021) Oliver Pain et al. PLoS Genetics
- Pharmacogenomics: A road ahead for precision medicine in psychiatry
- (2021) Antonio F. Pardiñas et al. NEURON
- An Investigation of Psychosis Subgroups With Prognostic Validation and Exploration of Genetic Underpinnings
- (2020) Dominic B. Dwyer et al. JAMA Psychiatry
- Special Article
- (2020) Rebecca Birnbaum et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Translating insights from neuropsychiatric genetics and genomics for precision psychiatry
- (2020) Elliott Rees et al. Genome Medicine
- A modelling approach to estimate the prevalence of treatment-resistant schizophrenia in the United States
- (2020) Michael Frank Mørup et al. PLoS One
- Leveraging correlations between variants in polygenic risk scores to detect heterogeneity in GWAS cohorts
- (2020) Jie Yuan et al. PLoS Genetics
- Polygenic prediction via Bayesian regression and continuous shrinkage priors
- (2019) Tian Ge et al. Nature Communications
- Clinical indicators of treatment-resistant psychosis
- (2019) Sophie E. Legge et al. BRITISH JOURNAL OF PSYCHIATRY
- PRSice-2: Polygenic Risk Score software for biobank-scale data
- (2019) Shing Wan Choi et al. GigaScience
- Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study
- (2019) Parita Shah et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Increased schizophrenia family history burden and reduced premorbid IQ in treatment-resistant schizophrenia: a Swedish National Register and Genomic Study
- (2019) Kaarina Kowalec et al. MOLECULAR PSYCHIATRY
- Schizophrenia polygenic risk scores, urbanicity and treatment-resistant schizophrenia
- (2019) Christiane Gasse et al. SCHIZOPHRENIA RESEARCH
- Psychiatric Genomics: An Update and an Agenda
- (2018) Patrick F. Sullivan et al. AMERICAN JOURNAL OF PSYCHIATRY
- Investigating heterogeneity of effects and associations using interaction terms
- (2018) Evangelos Kontopantelis et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection
- (2018) Antonio F. Pardiñas et al. NATURE GENETICS
- The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review
- (2018) Parita Shah et al. PSYCHIATRY RESEARCH
- Common genetic variants contribute to risk of rare severe neurodevelopmental disorders
- (2018) Mari E. K. Niemi et al. NATURE
- Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis
- (2018) Jian-Ping Zhang et al. AMERICAN JOURNAL OF PSYCHIATRY
- SumHer better estimates the SNP heritability of complex traits from summary statistics
- (2018) Doug Speed et al. NATURE GENETICS
- Advancing psychiatric genetics through dissecting heterogeneity
- (2017) Karen Hodgson et al. HUMAN MOLECULAR GENETICS
- Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease
- (2017) James C Lee et al. NATURE GENETICS
- Why do indiviuals with schizophrenia drop out of observational clinical trials?
- (2017) Alex Hofer et al. PSYCHIATRY RESEARCH
- Polygenic Risk Score for Schizophrenia and Treatment-Resistant Schizophrenia
- (2017) Theresa Wimberley et al. SCHIZOPHRENIA BULLETIN
- Genetic epidemiology and Mendelian randomization for informing disease therapeutics: Conceptual and methodological challenges
- (2017) Lavinia Paternoster et al. PLoS Genetics
- Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia
- (2017) Jari Tiihonen et al. JAMA Psychiatry
- Association between serum levels of glutamate and neurotrophic factors and response to clozapine treatment
- (2017) Amir Krivoy et al. SCHIZOPHRENIA RESEARCH
- LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis
- (2016) Jie Zheng et al. BIOINFORMATICS
- Correlates of Clozapine Use after a First Episode of Schizophrenia: Results From a Long-term Prospective Study
- (2016) Alp Üçok et al. CNS DRUGS
- A reference panel of 64,976 haplotypes for genotype imputation
- (2016) NATURE GENETICS
- Integrative approaches for large-scale transcriptome-wide association studies
- (2016) Alexander Gusev et al. NATURE GENETICS
- Profiling cognitive impairment in treatment-resistant schizophrenia patients
- (2016) Dorota Frydecka et al. PSYCHIATRY RESEARCH
- Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses
- (2016) J. Lally et al. PSYCHOLOGICAL MEDICINE
- Heritability of tic disorders: a twin-family study
- (2016) N. R. Zilhão et al. PSYCHOLOGICAL MEDICINE
- Phenome-wide analysis of genome-wide polygenic scores
- (2015) E Krapohl et al. MOLECULAR PSYCHIATRY
- LD Score regression distinguishes confounding from polygenicity in genome-wide association studies
- (2015) Brendan K Bulik-Sullivan et al. NATURE GENETICS
- Increased rare duplication burden genomewide in patients with treatment-resistant schizophrenia
- (2015) A. K. Martin et al. PSYCHOLOGICAL MEDICINE
- Second-generation PLINK: rising to the challenge of larger and richer datasets
- (2015) Christopher C Chang et al. GigaScience
- Research Review: Polygenic methods and their application to psychiatric traits
- (2014) Naomi R. Wray et al. JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY
- Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients
- (2014) J Frank et al. MOLECULAR PSYCHIATRY
- Evidence that duplications of 22q11.2 protect against schizophrenia
- (2013) E Rees et al. MOLECULAR PSYCHIATRY
- Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: Correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses
- (2013) Andrea de Bartolomeis et al. PSYCHIATRY RESEARCH
- Impact of diagnostic misclassification on estimation of genetic correlations using genome-wide genotypes
- (2012) Naomi R Wray et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC
- (2012) M L Hamshere et al. MOLECULAR PSYCHIATRY
- Defining treatment-resistant schizophrenia and response to antipsychotics: A review and recommendation
- (2012) Takefumi Suzuki et al. PSYCHIATRY RESEARCH
- Artifact due to differential error when cases and controls are imputed from different platforms
- (2011) Jennifer A. Sinnott et al. HUMAN GENETICS
- Treatment Pathway and Patterns of Clozapine Prescribing for Schizophrenia in New Zealand
- (2008) Amanda J Wheeler ANNALS OF PHARMACOTHERAPY
- Clozapine and “High-Dose” Olanzapine in Refractory Early-Onset Schizophrenia: A 12-Week Randomized and Double-Blind Comparison
- (2007) Sanjiv Kumra et al. BIOLOGICAL PSYCHIATRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started